Agoracom Blog Home

Posts Tagged ‘CSE’

« Older Entries
Newer Entries »

Loop Insights $MTRX.ca $RACMF Partners With NTT DATA, Top Ranked Global #IoT Services Company And Subsidiary Of Nippon Telegraph and Telephone, World’s 4th Largest Telecom Ranked 55th In Fortune Global 500 $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 12:40 PM on Thursday, December 17th, 2020
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

Partnership Marks Loop Insights’ Most Significant Partnership To Date 

  • Announced the signing of a global partnership agreement with NTT DATA Corp of Japan (TYO:9613), a global leader in technology services and a top-ranked global Internet of Things (IoT) consulting and system integration services company, with $USD 20-billion in revenues in 2020.
  • The two companies are working towards a finalized agreement with no financial commitments agreed upon at this time.
  • Loop and NTT DATA intend to combine their respective strengths to create new recurring revenue models for both companies.
  • For example, the NTT Smart platform, first introduced as a solution in building smarter, more connected cities, is now the cornerstone for its Back to Business Application.
  • Integrating Loop’s Insights and automated marketing capabilities with the NTT Smart Platform in a seamless manner is an obvious fit for both companies, each of which stands to benefit from the integration.

VANCOUVER, British Columbia, Dec. 17, 2020 — Loop Insights Inc. (MTRX:TSXV; RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick and mortar space, is pleased to announce the signing of a global partnership agreement with NTT DATA Corp of Japan (TYO:9613), a global leader in technology services and a top-ranked global Internet of Things (IoT) consulting and system integration services company, with $USD 20-billion in revenues in 2020. The two companies are working towards a finalized agreement with no financial commitments agreed upon at this time.

Loop and NTT DATA intend to combine their respective strengths to create new recurring revenue models for both companies. For example, the NTT Smart platform, first introduced as a solution in building smarter, more connected cities, is now the cornerstone for its Back to Business Application. Integrating Loop’s Insights and automated marketing capabilities with the NTT Smart Platform in a seamless manner is an obvious fit for both companies, each of which stands to benefit from the integration.

Loop Insights CEO Rob Anson stated, “Our partnership with NTT establishes Loop Insights as a global provider of IoT solutions for Venue Bubbles and Artificial Intelligence-driven automated marketing. As a result of this partnership, Loop will be exposed to global opportunities never thought possible earlier this year. For example, Loop’s successful live deployment of its Venue Bubble solution and its published capabilities with respect to its Travel Bubble solution will be the subject of work on major projects with NTT DATA. We thank William and his team for their confidence and look forward to accomplishing incredible things together in 2021.”

NTT DATA President William Baver stated, “NTT has developed a data platform to provide reactive and predictive analytics to help organizations achieve situational awareness related to any confined structure or area. This is a natural fit to the travel bubble concept that when paired with the Loop’s venue management solution, will provide our customers with the ability to ingest data from multiple sources and provide insights back via various APIs to allow customers to enjoy the best of both technologies. With respect to the various travel bubbles, we have the ability to bring the data tracking and data wallet details from Loop Insights to combine with situational awareness and data tracking from optical sensors, sound sensors, and other data sources surrounding this environment.”

NTT DATA – A TOP 10 GLOBAL IT SERVICES PROVIDER OPERATING IN MORE THAN 50 COUNTRIES

NTT DATA is a recognized leader in global technology services and a trusted global innovator, delivering technology-enabled services and solutions to clients around the world.

On April 2, 2020, NTT DATA was named “Top Ranked” for their global Internet of Things (IoT) consulting and system integration services by teknowlogy Group – a leading independent European research firm.

On February 6, 2020, the NTT DATA brand was ranked the world’s eighth most valuable brand among IT services providers according to UK-based Brand Finance, the world’s leading brand valuation and strategy consultancy.

Forbes named NTT Data to its list of Best Management Consulting Firms 2020

NTT DATA is a publicly-traded company with 123,000 employees and a current market capitalization of approximately $USD 18.5-billion. NTT DATA is approximately 54% owned by Nippon Telegraph and Telephone Corp.

NIPPON TELEGRAPH AND TELEPHONE CORP – ONE OF THE LARGEST TELECOM COMPANIES IN THE WORLD

Nippon Telegraph and Telephone Corp. (TYO: 9432) (“NTT”) is the fourth-largest telecommunications company in the world in terms of revenue and Ranked 55th in the Fortune Global 500 with a current market cap of approximately $USD 100-billion.

With approximately 310,000 employees worldwide, NTT is chosen by as many as 88% of the top 100 companies in the Global Fortune 500.

Globally NTT is recognized as one of the world’s largest information, communication, and technology companies. NTT’s operations and capabilities span six continents, connecting people and technologies. The depth and breadth of NTT’s global offerings span everything from mobile phones to data centers, with a strong foundation, focus, and corporate commitment to innovation. NTT helps clients achieve their business goals by creating, operating, maintaining, and evolving mission-critical IT systems and business processes.

NTT DATA PARTNERSHIP REPRESENTS SECOND MAJOR IOT PARTNERSHIP FOR LOOP INSIGHTS IN 2020

On October 15th, Loop announced the significant milestone of having been accepted into the Telus IoT Marketplace . The Company’s first product accepted into the IoT Marketplace was its contact tracing product, which has received significant exposure to many of TELUS’s largest customers and ongoing significant discussions with them. The third-party validation that came with this acceptance has been instrumental in Loop’s contact tracing discussions with large corporate customers around the world.

On December 3rd, Loop announced the Launch Of A Second Product Into The TELUS IoT Marketplace For National Sales and Marketing To TELUS Business Customers . The Company’s second product accepted into the IoT Marketplace was our Insights service which consists of our IoT Fobi device, Loop Cloud API, and AI Insights Portal that provide automated marketing capabilities. Connected between the printer and point of sale, Loop’s Fobi device’s real-time capabilities are driven by Artificial Intelligence to enhance the shopping experience. Providing data-driven product suggestions and unique discount codes for future use, Loop enables customers to increase revenues through increased spend per customer.

Loop Insights CEO Robert Anson added, “With two major IoT partnerships on two different continents, Loop is receiving unprecedented third-party validation and exposure to global opportunities that will be instrumental in the potential great success of our company in 2021 and beyond.”

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion And Management Engagement https://agoracom.com/ir/LoopInsights/forums/discussion

About NTT DATA

NTT DATA – a part of NTT Group – is a trusted global innovator of IT and business services headquartered in Tokyo. We help clients transform through consulting, industry solutions, business process services, digital & IT modernization, and managed services. NTT DATA enables them, as well as society, to move confidently into the digital future. We are committed to our clients’ long-term success and combine global reach with local client attention to serve them in over 50 countries around the globe. Visit us at nttdata.com

About Loop Insights

Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network.

For more information, please contact:

Loop Insights Inc. LOOP Website: www.loopinsights.ai
Rob Anson, CEO Facebook: @ LoopInsights
T : +1 877-754-5336 Ext. 4 Twitter: @ LoopInsights
E : [email protected] LinkedIn: @ LoopInsights

Forward-Looking Statements/Information:  

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: , , , , , , , , , , ,
Posted in Featured, Loop Insights Inc. | Comments Off on Loop Insights $MTRX.ca $RACMF Partners With NTT DATA, Top Ranked Global #IoT Services Company And Subsidiary Of Nippon Telegraph and Telephone, World’s 4th Largest Telecom Ranked 55th In Fortune Global 500 $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Quebec Pharmacists Launch #ECG Screening for the Prevention of Drug Induced Sudden Cardiac Death – CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 11:04 AM on Thursday, December 17th, 2020

HeartCheck™ CardiBeat and SMART Monitoring ECG Triaging to be used in Screening Services for detection of QT Prolongation in Community Pharmacies

  • Confirms the start of a pharmacy-based ECG monitoring service to screen for prolonged QT interval for the prevention of drug induced sudden cardiac death.
  • Under the Company’s Allied Health Professional Partner Program, the HeartCheck™ CardiBeat and GEMS™ Mobile Smartphone app will be used to collect ECGs recorded by patients under the direction of a pharmacist.
  • Recorded ECGs will be passed from the GEMS™ Mobile app to the Company’s SMART Monitoring ECG reading service to be triaged.
  • All findings will be sent directly to the pharmacist and any submitted ECG recordings that show a presence of prolonged QT interval or any other cardiac arrhythmia will be flagged so that the pharmacist may then follow up as needed with the patient’s treating physician.

TORONTO, ON / December 17, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) (“CardioComm” or the “Company“), a global provider of consumer heart monitoring and electrocardiogram (“ECG“) device and software solutions, confirms the start of a pharmacy-based ECG monitoring service to screen for prolonged QT interval for the prevention of drug induced sudden cardiac death.

Under the Company’s Allied Health Professional Partner Program, the HeartCheck™ CardiBeat and GEMS™ Mobile Smartphone app will be used to collect ECGs recorded by patients under the direction of a pharmacist. Recorded ECGs will be passed from the GEMS™ Mobile app to the Company’s SMART Monitoring ECG reading service to be triaged. All findings will be sent directly to the pharmacist and any submitted ECG recordings that show a presence of prolonged QT interval or any other cardiac arrhythmia will be flagged so that the pharmacist may then follow up as needed with the patient’s treating physician.

Pharmacists plan to run ECG tests on patients when picking up a prescription. All QT and QTc interval findings will be kept on file with the goal of recording QT measurements for any patient with known cardiac issues and starting any new medication known to influence the QT interval. “As polypharmacy analysis becomes more prevalent in a pharmacist’s daily tasks, the use of the HeartCheck™ CardiBeat device will allow staff to quickly measure the patient’s QT/QTc and make a clinical judgment as per the safety of the prescriptions being dispensed”, states pharmacist K. Manoukian.

QT interval prolongation is a recognized adverse drug reaction and risk factor for torsades de pointes (TdP), a fatal arrhythmia that can result in sudden cardiac death. While rare, the severity of TdP makes QT prolongation a serious concern when prescribing medications.

Pharmacists have a legal and professional responsibility to evaluate/mitigate medication adverse and serious adverse event risk factors and are the final decision makers in dispensing or not dispensing medications. The surface ECG is the only way to confirm or rule out the presence of a prolonged QT interval. The HeartCheck™ CardiBeat provides a useful tool as QT prolongation can now be easily, quickly and cost effectively obtained in community pharmacies and be compared to well established normal duration ranges. Without an ECG sudden cardiac death due to a prolonged QT interval may be the first and only evidence of the disease. Prior to the release of CardioComm’s ECG screening technologies, QT interval prolongation ECG screening was not available outside of the hospital setting.

Listings of medications known to cause TdP through acquired QT syndrome prolongation in healthy people (crediblemeds.org, sads.org.uk and heartcentre.ca) contain more than 100 common medications, many of which are dispensed by pharmacists. These include common antibiotics, medications to treat yeast infections, diuretics, anti-arrhythmia heart medications, and antidepressant and antipsychotic medications. Additionally, COVID-19 infection, a history of cardiac arrest and cardiovascular disease, age and women on heart medications are also known to increase the risk for cause acquired QT interval prolongation.

Through the screening service CardioComm will earn revenue from a per ECG QT interval triaging service fee. With the program now launched in Quebec, the Company will next look to the introduction of the QT interval ECG screening services in pharmacies and physician practices in other provinces.

To learn more about CardioComm’s products and for further updates regarding HeartCheck™ ECG device integrations, please visit the Company’s websites at www.cardiocommsolutions.com and www.theheartcheck.com.

About CardioComm Solutions

CardioComm Solutions’ patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions has earned the ISO 13485:2016 MDSAP certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health Canada).

FOR FURTHER INFORMATION PLEASE CONTACT:

Etienne Grima, Chief Executive Officer
1-877-977-9425 x227
[email protected]
[email protected]

Forward-looking statements

This release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management’s current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.

In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: CardioComm Solutions, Inc.

Tags: , , , , , , ,
Posted in CardioComm Solutions | Comments Off on Quebec Pharmacists Launch #ECG Screening for the Prevention of Drug Induced Sudden Cardiac Death – CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

VIDEO – FansUnite Entertainment $FANS.ca $FUNFF Makes History With First Ever Dedicated Esports Sportsbook In The United States $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM-JC at 9:23 AM on Thursday, December 17th, 2020

FansUnite Entertainment $FANS $FUNFF continues to live up to its name as the “Small Cap iGaming Super Company” by yet again announcing major news.  

This time, all it did was make history by becoming the first EVER dedicated esports sportsbook in the United States, along with partner GameCo.  

If that wasn’t enough, their originally announced $5M financing has now been upsized to $11,000,000, which should tell you how much demand this news has created.  

Watch this amazing interview with $FANS CEO, Scott Burton.

Tags: , , , , , , , , ,
Posted in AGORACOM Via Satellite, FansUnite Entertainment Inc. | Comments Off on VIDEO – FansUnite Entertainment $FANS.ca $FUNFF Makes History With First Ever Dedicated Esports Sportsbook In The United States $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

$HPQ.ca NANO Reaches Major Milestones With Gen 1 Nano Silicon Reactor Operational $EFL.ca $EGT.ca $ENPH $PYR.ca

Posted by AGORACOM-JC at 9:16 AM on Thursday, December 17th, 2020

New Era of Low-Cost Manufacturing of Nano Silicon Materials About to Commence

  • Announced today that technology provider PyroGenesis Canada Inc. ( TSX: PYR ) has informed HPQ NANO that phase 1 of the PUREVAP TM Nano Silicon Reactor (“NSiR”) development program has reached the commissioning stage, with the Gen1 PUREVAP TM NSiR now ready to start producing Silicon nano materials.
  • “The announcement today is indeed a major milestone and we are proud at having played a key role in this accomplishment. We are all extremely excited to have the Nano Reactor up and running, on schedule and on budget, particularly during these trying times.” said P. Peter Pascali CEO and Chairman of PyroGenesis Canada Inc.
  • Despite strong research and massive investment in Silicon material for batteries , current manufacturing processes are simply not scalable or commercially viable. With a capability of producing tailor made silicon materials within a wide range (from < 0.20 µm up to 5 µm), the PUREVAP TM NSiR represents a game changing leap forward in resolving the issues of commercial viability and scalability.

MONTREAL, Dec. 17, 2020  — Innovative silicon solutions provider HPQ Silicon Resources Inc. (“HPQ” or “the Company”) ( TSX-V: HPQ ; FWB: UGE ; Other OTC : URAGF ), through its wholly – owned subsidiary, HPQ Nano Silicon Powders inc (“HPQ NANO”), is pleased to announce today that technology provider PyroGenesis Canada Inc. ( TSX: PYR ) has informed HPQ NANO that phase 1 of the PUREVAP TM Nano Silicon Reactor (“NSiR”) development program has reached the commissioning stage, with the Gen1 PUREVAP TM NSiR now ready to start producing Silicon nano materials.

“The announcement today is indeed a major milestone and we are proud at having played a key role in this accomplishment. We are all extremely excited to have the Nano Reactor up and running, on schedule and on budget, particularly during these trying times.” said P. Peter Pascali CEO and Chairman of PyroGenesis Canada Inc. “The next major step is to get qualified samples into end user’s hands which we are pushing to do before year-end, or shortly afterwards. The more we progress with the Nano reactor the more it seems to us to be a real game changer. It may very well become the gold standard for making nano Si for the battery industry. Success to date bodes well for the future, and today’s announcement is one major step in that direction”.

PUREVAP TM NSiR LOW-COST SPHERICAL SILICON MATERIALS: A GAME CHANGING LEAP

Despite strong research and massive investment in Silicon material for batteries , current manufacturing processes are simply not scalable or commercially viable. With a capability of producing tailor made silicon materials within a wide range (from < 0.20 µm up to 5 µm), the PUREVAP TM NSiR represents a game changing leap forward in resolving the issues of commercial viability and scalability.

With the Gen1 NSiR now operational, HPQ NANO will be uniquely positioned to be able to offer industry participants a wide spectrum of products for testing, while we advance phase 2 of the PUREVAP TM NSiR development program towards the confirmation of the scalability of the process in order to increase our capacity to meet the anticipated emerging demands from battery, EV manufactures and other markets looking for nano silicon materials.

Image 1) HPQ NANO Phase 1 and Phase 2 project timelines is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/5fd1fc40-2f1b-408d-965f-4763be214bef

“First, let me thank the PyroGenesis team for getting the Gen1 PUREVAP TM NSiR operational, on time and on budget, during these challenging times . T his is a major and critical milestone for us. Having the capability to produce Silicon nanopowders and nanowires will allow HPQ to be at the forefront of Nano Silicon for batteries as we continue working on scaling up the capacities of our next generation of PUREVAP TM NSiR reactors. This is another demonstration of the depth and flexibility of HPQ’s R&D consortium as we strive to produce products for renewable energy storage participants and electric vehicle manufacturers, who are searching for cost effective ways of increasing the Silicon contained in their batteries. ,” said Bernard Tourillon, President and CEO HPQ Silicon. “Silicon’s potential to meet energy storage demand is undeniable, generating massive investments , and serious industry interest. We are very confident that demand for the Silicon materials we will produce, with our low-cost scalable processes, will be in high demand by batteries and EV manufacturers in this renewable energy revolution.”

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit www.pyrogenesis.com .

About HPQ Silicon

HPQ Silicon Resources Inc. ( TSX-V: HPQ ) is a Canadian Innovative Silicon Solutions Provider.

Silicon (Si), also known as silicon metal, is one of today’s key strategic materials needed for the decarbonization of the economy and the Renewable Energy Revolution (“RER”).

Silicon is the most abundant element in earth’s crust but does not exist in its pure state and must be extracted from quartz (SiO 2 ) in what has historically been a capital and energy intensive process. HPQ is building a portfolio of silicon–based products using innovative scalable processes. The target objective is to produce high value speciality Silicon products using technologies that will reduce energy consumption, GHG’s, and carbon footprint.

Working with PyroGenesis Canada Inc. ( TSX: PYR ) , a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAP TM “Quartz Reduction Reactors” (QRR) , an innovative process (patent pending), which will permit the one step transformation of quartz (SiO 2 ) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential .

    • HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si).
  • Through its 100% owned subsidiary HPQ NANO Silicon Powders Inc, the PUREVAP TM Nano Silicon Reactor (NSiR ) , a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires.

    • HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries .

    • During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAP TM SiNR .

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders.

    • The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries.
    • Develop the hydrogen generation potential of Silicon nanopowders for use with the Gennao TM system.
    • Commercialize, exclusively in Canada, and non-exclusive in the U.S.A., the Gennao TM H 2 system and the chemical powders required for the hydrolysis production of Hydrogen (“H2”).

This News Release is available on the company’s CEO Verified Discussion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

Tags: , , , , , , , ,
Posted in Featured, HPQ-Silicon Resources Inc. | Comments Off on $HPQ.ca NANO Reaches Major Milestones With Gen 1 Nano Silicon Reactor Operational $EFL.ca $EGT.ca $ENPH $PYR.ca

PlantX $VEGA.ca announces expansion into Israel $BYND $TSN $CAG $FMCI $VERY $MEAT

Posted by AGORACOM-JC at 8:53 AM on Thursday, December 17th, 2020
PlantX | LinkedIn
  • Announced its plans to expand the Company’s e-commerce platform into the State of Israel .
  • The Company’s Israeli expansion will also include establishing a future brick and mortar PlantX location in the country.
  • Company owns the domain www.PlantX.co.il and will be launching it with the flagship brick and mortar location. PlantX Israel customers will receive the same PlantX online experience and services as its North American customers, including plant-based meal delivery, indoor plant delivery, access to plant-based products, updated weekly recipes, a plant-based restaurant locator and informational articles regarding plant-based trends.

VANCOUVER, BC , Dec. 17, 2020 – PlantX Life Inc. (the ” Company ” or ” PlantX “) (CSE: VEGA ) (Frankfurt: WNT1) is pleased to announce its plans to expand the Company’s e-commerce platform into the State of Israel . The Company’s Israeli expansion will also include establishing a future brick and mortar PlantX location in the country.

Today’s announcement follows yesterday’s announcement of Psagot Investment House Ltd., an Israeli investment firm and Israel’s largest pension fund manager, leading the Company’s recently closed non-brokered $11.5 million private placement (for further details, please see the Company’s press release dated December 16, 2020 ).

PlantX Israel’s operations will be led by VP of Israel Operations Ms. Mili Ben-David and VP of Global Expansion Mr. Michael Blicher . Ms. Ben-David currently lives in the country and Mr. Blicher will be relocating to Israel to join the PlantX team. Ms. Ben-David and Mr. Blicher will be tasked with finding a suitable site for PlantX’s first brick and mortar location in Israel , building partnerships with local brands and chefs, and establishing and growing the PlantX community in the country. The duo will also help introduce popular plant-based US brands to Israel and importing popular Israeli plant-based brands to PlantX’s North American market.

” Israel overall has a strong leaning towards plant-based products due both to emerging trends and dietary laws that many Israeli Jews follow that prohibit meat or dairy following eating one or the other,” said Mr. Blicher, PlantX VP of Global Expansion. “We are thrilled and excited to expand our e-commerce platform to another international market, to provide Israeli consumers with enhanced choice, widen our product offerings with Israeli brands, and offer the unique PlantX shopping and customer service experience to Israel .”

The Company owns the domain www.PlantX.co.il and will be launching it with the flagship brick and mortar location. PlantX Israel customers will receive the same PlantX online experience and services as its North American customers, including plant-based meal delivery, indoor plant delivery, access to plant-based products, updated weekly recipes, a plant-based restaurant locator and informational articles regarding plant-based trends. The Israeli plant-based offerings will include an assortment of products including pantry essentials, groceries, vitamins, cosmetics and pet food.

PlantX’s Israeli expansion plans include the establishment of franchise locations across the country. The expansion of turnkey retail solutions and franchises in Israel will be led by Israeli-founded Iris Construction Management (” Iris “). Iris’ founders share a vision with PlantX to spread health, wellness and plant-based education to consumers. This partnership with Iris will allow PlantX to continue in its pursuit of becoming a one-stop shop for everything plant-based and a digital leader in the plant-based community.

“An advantage of working with Iris Construction Management is that our expertise has been proven across the world,” said Scott Kurz , Iris Construction Management Development Manager. “We can help franchises grow their business on a global scale and we are proud to help PlantX bring their innovative brand to Israel .”

“The Mediterranean diet has plenty of flavours with many vegan dishes,” said Ms. Ben-David. “Eating plant-based products was a way of survival, since the days of the ‘Kibbutz.’ This simplicity is still what we see on the table, especially at an Israeli breakfast table, which are known for their extensive spread of vegetables, grains and many different types of salads.”

PlantX continues to advance its plans to open its first brick and mortar locations in San Diego, California and Squamish, British Columbia , with plans for future franchises across North America .

Once complete, PlantX’s location in Israel will be the Company’s first overseas brick and mortar location and will feature a shop with a wide-variety of plant-based products, a plant-based café, a restaurant with plant-based pre-made meals and an education center for consumers to learn more about plant-based living. PlantX plans to continue to expand its e-commerce platform to other countries with new and exciting partnerships, acquisitions and verticals in the plant-based industry.

“Seeing our company grow around the world so quickly is very exciting and we could not be more pleased with our expansion,” said Sean Dollinger , PlantX founder. “When we have two incredible people like Michael and Mili on the ground in Israel and Iris Construction Management from Israel , it just makes a lot of sense.”

Corporate Update

PlantX announces that it has granted 1,870,000 incentive stock options (the ” Options “) to purchase common shares of PlantX (” Common Shares “) to certain consultants of the Company. The Options are exercisable for a five (5) year period at a price of $1.45 per share. One quarter (1/4) of the Options will vest every three months from the date of grant.

PlantX also announces that it has granted 4,153,000 restricted share units (” RSUs “) to certain directors, officers and consultants of the Company pursuant to the Company’s restricted share unit plan (” RSU Plan “). The RSUs have a term of one (1) year of which one quarter (1/4) of the RSUs will vest every three (3) months from the date of grant. The RSUs will not vest or be paid out until the RSU Plan has been approved and ratified by shareholders. The Company intends to seek shareholder approval of the RSU Plan at the Company’s next annual general meeting. Further details regarding the RSU Plan will be set out in the management information circular of the Company, which will be mailed to shareholders and filed on SEDAR in connection with the Company’s next annual general meeting.

PlantX also announces that it will issue an aggregate of 437,931 Common Shares to a consultant of the Company (the ” Consultant “), at a deemed price of $1.45 per Common Share for services rendered in accordance with the terms of a consulting agreement with the Company. The Common Shares issued to the Consultant will be subject to a 4 month hold period from the date of issuance in accordance with the policies of the CSE.

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop-shop for everything plant-based. With its fast growing category verticals, the Company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include cosmetics, clothing, and its own water brand — but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of like-minded consumers, and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs, and brands. The Company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier, and happier life.

The Company website is http://investor.PlantX.com/ .

Forward Looking-Information

This press release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. The forward-looking information contained herein includes, without limitation, statements relating to the Company’s expansion into Israel , the establishment of brick and mortar locations in San Diego, CA , Squamish, BC and Israel , the receipt of shareholder approval of the RSU Plan and the vesting and settlement of the RSUs, and the business and strategic plans of the Company.

By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: the Company’s ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; a limited operating history, the ability of the Company to access capital to meet future financing needs; the Company’s reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.

Additional risk factors can also be found in the Company’s continuous disclosure documents which have been filed on SEDAR and can be accessed at www.sedar.com . Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , , , ,
Posted in PlantX Life Inc. | Comments Off on PlantX $VEGA.ca announces expansion into Israel $BYND $TSN $CAG $FMCI $VERY $MEAT

VIDEO – KWESST Micro Systems $KWE.ca Soldier Launched Micro Drones, Electronic Soldier Decoys and a $1.1 Million Dollar Follow-On Order From A Key US Military Customer $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 8:45 AM on Thursday, December 17th, 2020

If you haven’t heard of KWESST Micro Systems (KWE:TSXV) you’re not alone because the Company just listed for trading a couple of months ago – and it is probably the coolest new listing of 2020 if you love high-tech, covert defense systems that we only get to see in Tom Cruise movies.

KWESST is a leader in “soldier systems” which are technologies that increase the capabilities of soldiers,  Let’s be clear right off the start, KWESST doesn’t sell weaponry.  Rather, it sells technologies that make a big difference to the safety and effectiveness of soldiers.

For example, out in a field of combat, soldiers emit Electro Magnetic (EM) signatures that make them detectable by enemy combatants.  KWESST has a battlefield decoy system that creates multiple false phantom signatures to spoof adversaries.  This picture is worth 1,000 words.

We could go on about many other such technologies created by KWESST but this is AGORACOM after all and we want to get down to the business of KWESST, the highlights of which are as follows: 

  • A developer of next-generation systems for forces around the world, including those of NATO and its allies
  • A leadership team whose experience spans decades and hundreds of millions of dollars in military and homeland security contracts
  • A sales and distribution network of agents that spans the globe
  • Partnerships with globally recognized OEM’s, including Samsung
  • A sales pipeline that stood at  $93,000,000 (not a typo) as of August 2020
  • Already generating revenues in 2020

And last but not least, a secret weapon in its Executive Chairman David Luxton, whose companies under his leadership have generated over $1,000,000,000 (Yes, BILLION).

The soldier systems market is projected to hit $14.5 Billion by 2023 and, up until  now, small cap investors have never had a company to participate in this lucrative (and SUPER COOL) market.

Now you do.  Meet KWESST Micro Systems.  Watch this great interview with David Luxton himself to learn more about KWE and why it just received a follow-on order for $1.1 Million from a key US Military Customer.  We’d tell you who it is but we’d then have to release KWE micro drones …. you know the rest.

Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.

Tags: , , , , , , ,
Posted in AGORACOM Via Satellite, KWESST Micro Systems Inc. | Comments Off on VIDEO – KWESST Micro Systems $KWE.ca Soldier Launched Micro Drones, Electronic Soldier Decoys and a $1.1 Million Dollar Follow-On Order From A Key US Military Customer $WRTC $BYRN.ca $PAT.ca $POWW

Avicanna $AVCN.ca $AVCNF Expands Distribution Network in South America Through Commercial Partnerships in Ecuador and Commercial Export of Feminized Seeds to Uruguay $KHRN.ca $TRUL.ca $VFF.ca

Posted by AGORACOM-JC at 7:39 AM on Thursday, December 17th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg
  • Partnership with Alliancepharma Technologies S.A., one of Ecuador’s largest pharmaceutical companies, will take advantage of the upcoming cannabis regulations to allow for the registration and distribution of several of Avicanna’s consumer and pharmaceutical products across Ecuador
  • Distribution agreement with Spenta S.A., an Ecuadorian cosmetic distributor, for the distribution of its derma-cosmetic product line branded as Pura Earth TM
  • Successful registration and export of CBD and CBG dominant feminized seeds to Uruguay from Colombia

TORONTO, Dec. 17, 2020 — Avicanna Inc. (“ Avicanna ” or the “ Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that it has entered into an importation and distribution agreement with Alliancepharma Technologies S.A. (“ Alliancepharma ”) for the distribution of Avicanna’s advanced and clinically supported medical and pharmaceutical formulations in Ecuador. Avicanna has also entered into an agreement with Spenta S.A. (“ Spenta ”), an Ecuadorian cosmetic distributor, for the distribution of its Pura Earth branded derma-cosmetic product line nationwide. As part of its commercial expansion plans, Avicanna has also completed an export of feminized seeds to Uruguay from its majority-owned cultivation subsidiary, Santa Marta Golden Hemp S.A.S. (“ SMGH’ ) in Santa Marta, Colombia.

Avicanna’s exclusive agreement with Alliancepharma will take advantage of the upcoming Ecuadorian regulations of cannabis-based products and allow for the registration and commercialization of Avicanna’s advanced cannabinoid-based consumer and pharmaceutical products in the Ecuadorian market. The product offerings include Avicanna’s deep tissue topical formulations marketed as consumer products in addition to several pharmaceutical products that are intended to be registered as indication specific drugs and natural medicines. Alliancepharma, a part of the Naturex group and one of the largest pharmaceutical companies in Ecuador, is expected to leverage its in-house distributionand commercialization capabilities as well as its network of nation-wide pharmacies to bring Avicanna’s products to consumers all over the country upon the regulations in Ecuador coming into effect.

“We are very excited to enter the Ecuadorian market with the first cannabinoid-based pharmaceutical products with the support of a world class partner such as Avicanna Inc. This partnership strengthens our commitment as pioneers and leaders in the pharmaceutical industry, offering innovative phyto-therapeutic solutions to continue improving the quality of life of our patients.” Stated Diego Vega, International Business Development Director of Alliancepharma.

Avicanna’s Pura Earth branded derma-cosmetic products are expected to enter the Ecuadorian market through Spenta’s distribution nationwide network of pharmacies, beauty retailers and e-commerce platforms. The agreement with Spenta coincides with an initial purchase order of several SKU’s which is expected to be exported from Colombia in Q1-2021. This will become the second South American market after Colombia in which the Pura Earth branded derma-cosmetic products will be available for sale. The derma-cosmetic formulations, which synergistically combine natural ingredients with hemp-derived CBD, have been developed through a rigorous scientific and evidence-based approach that includes positive results from the completion of 3 cosmetic human clinical studies.

As part of the Company’s commercial expansion plans, Avicanna’s majority owned subsidiary, SMGH, has completed the registration of its CBD and CBG dominant genetics in Uruguay and a commercial export of feminized non-psychoactive cannabis seeds to Uruguay. This marks three countries in which Avicanna’s seeds are currently commercially sold including the United States and Colombia. As a global cannabis and hemp cultivation industry begins to emerge, Avicanna’s industry leading genetics program seeds business unit is well positioned to be a reliable supplier of high quality seeds.

Lucas Nosiglia, President of Avicanna LATAM, commented: “We continue to demonstrate leadership across the LATAM markets and validate our diverse business model which is dedicated to quality cannabinoid products across the full value chain. We are optimistic about the opportunity in LATAM markets as we continue to see the regulations and business opportunities evolve and believe our medical and scientific superiority combined with our sustainable and economical costs positions us at the forefront of this emerging sector.”

To the knowledge of the Company, it is in compliance with all applicable laws in the jurisdictions in which it operates.

About Avicanna Inc.

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.

Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:

  • Pura Earth™ or Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
  • RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all 2 developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.

With ongoing clinical trials on its derma-cosmetic (branded as Pura Earth or Pura H&W), medical cannabis (branded as RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.

Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.

SOURCE Avicanna Inc.

Stay Connected

For more information about Avicanna, visit www.avicanna.com , call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected] .

Cautionary Note Regarding Forward-Looking Information and Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the ability of the Company to manufacture any of the products, the ability of the Company to export any of the products, the ability of Alliancepharma or Spenta to distribute the products, the regulations coming into full force and effect in Ecuador, and the ability of SMGH to continue to complete exporting cannabis seeds to Uruguay . Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020 and final short form prospectus dated November 27, 2020, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com .

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Tags: , , , , , , , , , , , ,
Posted in Avicanna Inc., Featured | Comments Off on Avicanna $AVCN.ca $AVCNF Expands Distribution Network in South America Through Commercial Partnerships in Ecuador and Commercial Export of Feminized Seeds to Uruguay $KHRN.ca $TRUL.ca $VFF.ca

Kontrol $KNR $KNR.ca $KNR.c $KNRLF to host BioCloud Event for Investors, Analysts and Media – TODAY 4:30 PM Eastern $SNE $MSFT $HON $GOOGL $QCOM

Posted by AGORACOM-JC at 7:27 AM on Thursday, December 17th, 2020
kontrol-logo

TORONTO , Dec. 9, 2020 – Kontrol Energy Corp. ( CSE: KNR ) ( OTCQB: KNRLF ) ( FSE: 1K8 ) (” Kontrol ” or ” Company “) is pleased to announce that it will be hosting a webinar presentation  for investors, analysts and media for its Covid-19 detection technology (“BioCloud analyzer” or “BioCloud”). The purpose of the presentation is to provide an operating demonstration and take questions from the audience.

“Following the filing of our patent applications we are excited to demonstrate how the BioCloud technology operates and share that with the public,” says Paul Ghezzi , CEO Kontrol. “We will be providing a demonstration of BioCloud and access to the inner workings of the technology.”

As previously announced on November 30, 2020 , Kontrol has filed the following four patent applications for its BioCloud technology and the Company is pleased to provide the patent references:

UNITED STATES : Application No. 17/105,793
SYSTEM AND METHOD FOR DETECTING AIRBORNE PATHOGENS

UNITED STATES : Application No. 17/105,813
SYSTEM AND METHOD FOR OPTICAL DETECTION OF PATHOGENS

UNITED STATES : Application No. 17/105,804
COLLECTION CHAMBER FOR AN AIR SAMPLING SYSTEM

CANADA
SYSTEM AND METHOD FOR DETECTING AIRBORNE PATHOGENS

Title:Kontrol to Host BioCloud Technology Presentation for Investors, Analysts and Media
  
Event Date:Thursday, December 17, 2020 – 4:30 PM Eastern Time
  
Presentation Type:Audio with Presenter Controlled Slides and Teleconference
  
Event Link:Webcast URL:
https://www.webcaster4.com/Webcast/Page/2402/39134
  
Participant
Numbers:		Toll Free: 877-407-0782 International: 201-689-8567

About Kontrol BioCloud TM

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.

Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com

BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Trademark.

About Kontrol Energy

Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date.  Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

Tags: , , , , , ,
Posted in All Recent Posts, Kontrol Energy Corp. | Comments Off on Kontrol $KNR $KNR.ca $KNR.c $KNRLF to host BioCloud Event for Investors, Analysts and Media – TODAY 4:30 PM Eastern $SNE $MSFT $HON $GOOGL $QCOM

Datametrex AI $DM.ca $DTMXF Ramps up COVID-19 Testing for Film & Television Sectors $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:22 AM on Thursday, December 17th, 2020
  • As of this coming January 2021, the Company has received order for an additional 3 film & TV productions in Toronto and an additional 6 l film & TV productions in Vancouver.
  • The Company is currently providing services to 6 production companies in Toronto and 11 production companies in Vancouver, administering approximately 6,000 tests per week.
  • The Company expects this will increase significantly with the additional projects which is seeing in its project pipeline.

Toronto, Ontario–(December 17, 2020) – Datametrex AI Limited  (TSXV: DM) (FSE: D4G) (OTC: DTMXF) (the “Company” or “Datametrex”) wishes to provide an update on film and television industry testing and lab facilities projects which it is undertaking in Canada.

As of this coming January 2021, the Company has received order for an additional 3 film & TV productions in Toronto and an additional 6 l film & TV productions in Vancouver. The Company is currently providing services to 6 production companies in Toronto and 11 production companies in Vancouver, administering approximately 6,000 tests per week. The Company expects this will increase significantly with the additional projects which is seeing in its project pipeline.

Datametrex has ramped up testing lab facilities in Vancouver. The lab now has a capacity of processing up to 10,000 COVID-19 tests per week with the ability to expand this capacity even further (if required).

Vancouver is the third-largest production centre in North America, worth CDN $3.2 billion during 2018/19, according to Creative BC. British Columbia is home to several world-class Film and TV studios, including Bridge Studios, Mammoth Studios, Vancouver Film Studios, North Shore Studios, Ironwood Studios, Canadian Motion Picture Park, and The Crossing Studios. (Source: CreativeBC Film Commission)

Entire film and TV production in Canada represent $8.92 billion in production volume, and full-time equivalent jobs represent 179,000 workers. In March 2020, the industry stopped worldwide and in Vancouver which represents 37% of Canadian productions, and the surrounding areas had 46 productions filming which does not include the TV commercial market. Each of the shows would have a minimum of a 100-person film crew. (Source: CreativeBC Film Commission)

The next largest film and television market is Ontario which represents 34% of Canadian productions and in 2019, Toronto’s film and television industry directly employed more than 28,000 people representing $3.17 billion in production volume. (Source: CreativeBC Film Commission)

“With Vancouver and Toronto feature-length movies and episodic series productions filming quickly ramping up, we feel that this will only expand the COVID-19 screening business for the film and TV industries,” said Marshall Gunter CEO of the Company.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain “forward-looking information” or constitute “forward-looking statements” within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy, including the dollar amount of revenue anticipated under the Agreement.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , , , , , , ,
Posted in Datametrex AI Limited | Comments Off on Datametrex AI $DM.ca $DTMXF Ramps up COVID-19 Testing for Film & Television Sectors $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

FansUnite Entertainment $FANS.ca $FUNFF Announces Upsizing of Previously Announced Brokered Private Placement Led by Gravitas Securities Inc. to $11 Million Due to Strong Investor Demand $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM-JC at 10:00 PM on Wednesday, December 16th, 2020
  • Pursuant to the increase, the Company will offer for sale up to an aggregate of 17,600,000 special warrants of the Company at a price of $0.625 per Special Warrant for aggregate gross proceeds of approximately $11 million
  • “Due to overwhelming demand from a broad range of investors, we have decided to increase our private placement offering to $11M from our previously announced target of $5M,” said Scott Burton, CEO of FansUnite Entertainment. “The upsizing of our financing provides us with confidence that the investment community believes in our continued vision of becoming a leader in the global iGaming industry, while providing us the necessary capital to pursue strategic opportunities to enhance shareholder value.”

Vancouver, British Columbia–(December 16, 2020) – FansUnite Entertainment Inc. (CSE: FANS) (OTCQB: FUNFF) (“FansUnite” or the “Company“), a technology company providing leading online gaming solutions, is pleased to announce that, due to strong investor demand, it has entered into an amended agreement with Gravitas Securities Inc., as lead agent and sole bookrunner (the “Lead Agent“) on its own behalf and, on behalf of a syndicate of agents including, Haywood Securities Inc. and Mackie Research Capital Corporation (collectively with the Lead Agent, the “Agents“), to increase the size of the previously announced private placement of the Company.

Pursuant to the increase, the Company will offer for sale up to an aggregate of 17,600,000 special warrants of the Company (the “Special Warrants“) at a price of $0.625 per Special Warrant for aggregate gross proceeds of approximately $11 million (the “Offering“). The Company has also amended the option granted to the Agents, to provide for the sale of up to an additional 2,640,000 Special Warrants (the “Over-Allotment Option“), which Over-Allotment Option is exercisable in whole or in part at any time up to 30 days following the closing of the Offering. The initial closing date is expected to be on or about the week of January 11th, 2021 (the “Closing Date” or “Closing“) and the Offering may be completed in one or more closings at the discretion of the Lead Agent.

Each Special Warrant shall be exercisable, for no additional consideration at the option of the holder, into one unit of the Company (each, a “Unit“), with each Unit being comprised of one common share of the Company (a “Common Share“) and one half (1/2) of one non-transferable Common Share purchase warrant (each whole warrant, a “Warrant“). Each Warrant will entitle the holder thereof to acquire one Common Share (each, a “Warrant Share“) at an exercise price of $0.78 per Warrant Share for a period of 24 months after Closing (the “Expiry Date“).

“Due to overwhelming demand from a broad range of investors, we have decided to increase our private placement offering to $11M from our previously announced target of $5M,” said Scott Burton, CEO of FansUnite Entertainment. “The upsizing of our financing provides us with confidence that the investment community believes in our continued vision of becoming a leader in the global iGaming industry, while providing us the necessary capital to pursue strategic opportunities to enhance shareholder value.”

The net proceeds raised under the Offering will be used for working capital and general corporate purposes.

As soon as reasonably practicable after the Closing, the Company will prepare and file with each of the securities regulatory authorities in each of the provinces of British Columbia, Alberta, Manitoba and Ontario, (the “Jurisdictions“) and obtain a receipt for, a final short form prospectus (the “Final Prospectus“), qualifying the distribution of the securities issued pursuant to the Offering, in compliance with applicable securities law, within sixty (60) days from the Closing of the Offering.

In the event that the Company has not received a receipt for the Final Prospectus within sixty (60) days following the Closing, each unexercised Special Warrant will thereafter entitle the holder thereof to receive upon the exercise thereof, at no additional consideration, one-and-one-tenth (1.10) Unit (instead of one Unit) (the “Penalty Ratio“), provided that nothing shall require the Company to issue fractional Units or Common Shares and Warrant Shares underlying such Units, and any fractions resulting from the application of the Penalty Ratio shall be rounded down to the nearest whole number.

This press release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.

About FansUnite Entertainment Inc.

FansUnite is a global sports and entertainment company, focusing on technology related to regulated and lawful online gaming and other related products. FansUnite has produced a one of a kind complete iGaming platform, with a sports and esports focus geared for the next generation of online bettors and casino players. The platform includes products for pre-match betting, in-play betting, daily fantasy, content and a certified RNG to produce casino style chance games. The platform operates multiple B2C brands and B2B software for the online gambling industry. FansUnite also looks to acquire technology platforms and assets with high growth potential in new or developing markets.

For further information, please contact:

Prit Singh Investor Relations at FansUnite
[email protected]
(905) 510-7636

Scott Burton Chief Executive Officer of FansUnite
[email protected]

Darius Eghdami President of FansUnite
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

FORWARD-LOOKING STATEMENTS: Certain information contained herein may constitute “forward-‎looking information” under Canadian securities legislation. Generally, forward-looking information can be ‎identified by the use of forward-looking terminology such as “believes,” “belief,” “expects,” “intends,” ‎‎”anticipates,” “potential,” “should,” “may,” “will,” “plans,” “continue” or similar expressions to be uncertain ‎and forward-looking. Forward-looking statements may include, without limitation, statements relating to ‎future outlook and anticipated events such as: the Offering, the use of proceeds from the Offering, the filing and receipt for the Final Prospectus, the ‎Company’s unique portfolio of assets; and discussion of future plans, projections, objectives, estimates ‎and forecasts and the timing related thereto. Forward-looking statements are based on the Company’s ‎estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the ‎actual results, level of activity, performance or achievements of FansUnite to be materially different from ‎those expressed or implied by such forward-looking statements or forward-looking information. Additional ‎information regarding the risks and uncertainties relating to the Company’s business are contained under ‎the heading “Risk Factors” in the Company’s Non-Offering Prospectus dated March 27, 2020 filed on its ‎issuer profile on SEDAR at www.sedar.com and risks related to global pandemics, including the novel ‎coronavirus (COVID-19) global health pandemic, and the spread of other viruses or pathogens and influence ‎of macroeconomic developments. Accordingly, readers should not place undue reliance on forward-looking ‎statements and forward-looking information. The forward-looking statements in this news release are made ‎as of the date of this release. FansUnite disclaims and does not undertake to update or revise any forward-‎looking statements or forward-looking information, whether as a result of new information, future events or ‎otherwise, except as required by applicable securities laws.

Tags: , , , , , , , ,
Posted in FansUnite Entertainment Inc. | Comments Off on FansUnite Entertainment $FANS.ca $FUNFF Announces Upsizing of Previously Announced Brokered Private Placement Led by Gravitas Securities Inc. to $11 Million Due to Strong Investor Demand $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

« Older Entries
Newer Entries »